Spinal Cord Stimulator Helps Treat Chronic Pain
|
By HospiMedica International staff writers Posted on 12 Feb 2019 |

Image: A new implanted device blocks pain signals from reaching the brain (Photo courtesy of Boston Scientific).
A new spinal cord stimulator (SCS) system combines paraesthesia and sub-perception therapy to treat chronic and debilitating pain.
The Boston Scientific (Natick, MA, USA) Spectra WaveWriter is an implanted SCS system designed to help in the management of chronic obdurate pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable lower back and leg pain, complex regional pain syndrome (CRPS), radicular pain syndrome, and radiculopathies resulting in secondary pain, such as failed back surgery, a herniated disc, degenerative disc disease (DDD), and others.
The two main components of the system are the signal generator, implanted under the skin, which sends electrical stimulation signals to the spinal cord through an insulated lead wire, and a hand-held remote control that allows the patient to control it. The signal generator is programmed to produce electrical signals that can block pain signals traveling to the patient's brain through a combination of novel sub-perception algorithms and waveform automation. Studies have shown an improvement in pain of 29.2-100% for CRPS patients, and 37-77% for those with back and leg pain due to surgery-associated conditions.
“We are introducing industry-leading SCS technology to help provide patients with lasting relief from chronic pain,” said Maulik Nanavaty, president and senior vice president of neuromodulation at Boston Scientific. “We are committed to investing in research and expanding treatment options for chronic pain by identifying new, non-opioid solutions for the millions of people suffering from this debilitating condition.”
“Pain is very personal, and everyone experiences it differently. Pain also changes over time, which for chronic pain patients means that their bodies may become accustomed to treatment and its effectiveness declines,” said Vivek Mehta, a consultant in pain medicine at Queen Mary, University of London (QMUL; United Kingdom). “The Spectra WaveWriter SCS system allows us to combine multiple treatment options in one single device, intended to give patients truly personalized therapy that evolves just as their pain does to provide lasting relief.”
SCS works by sending electrical impulses to the spinal cord, masking the pain signals travelling to the brain. These electrical impulses can vary in frequency, pulse width, and amplitude, providing pain relief with a light tingling sensation known as paraesthesia-based therapy or with sub-perception therapy that works without sensation.
The Boston Scientific (Natick, MA, USA) Spectra WaveWriter is an implanted SCS system designed to help in the management of chronic obdurate pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable lower back and leg pain, complex regional pain syndrome (CRPS), radicular pain syndrome, and radiculopathies resulting in secondary pain, such as failed back surgery, a herniated disc, degenerative disc disease (DDD), and others.
The two main components of the system are the signal generator, implanted under the skin, which sends electrical stimulation signals to the spinal cord through an insulated lead wire, and a hand-held remote control that allows the patient to control it. The signal generator is programmed to produce electrical signals that can block pain signals traveling to the patient's brain through a combination of novel sub-perception algorithms and waveform automation. Studies have shown an improvement in pain of 29.2-100% for CRPS patients, and 37-77% for those with back and leg pain due to surgery-associated conditions.
“We are introducing industry-leading SCS technology to help provide patients with lasting relief from chronic pain,” said Maulik Nanavaty, president and senior vice president of neuromodulation at Boston Scientific. “We are committed to investing in research and expanding treatment options for chronic pain by identifying new, non-opioid solutions for the millions of people suffering from this debilitating condition.”
“Pain is very personal, and everyone experiences it differently. Pain also changes over time, which for chronic pain patients means that their bodies may become accustomed to treatment and its effectiveness declines,” said Vivek Mehta, a consultant in pain medicine at Queen Mary, University of London (QMUL; United Kingdom). “The Spectra WaveWriter SCS system allows us to combine multiple treatment options in one single device, intended to give patients truly personalized therapy that evolves just as their pain does to provide lasting relief.”
SCS works by sending electrical impulses to the spinal cord, masking the pain signals travelling to the brain. These electrical impulses can vary in frequency, pulse width, and amplitude, providing pain relief with a light tingling sensation known as paraesthesia-based therapy or with sub-perception therapy that works without sensation.
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







